Bleeding risk and incidence in real world percutaneous coronary intervention patients with ticagrelor

Heart Lung Circ. 2015 Apr;24(4):404-6. doi: 10.1016/j.hlc.2014.10.006. Epub 2014 Oct 30.

Authors

Ivan Subiakto¹, Muhammad Asrar ul Haq², William J Van Gaal²

Affiliations

¹ The Northern Hospital, Cardiology Department, Epping, Victoria, Australia. Electronic address: [email protected].
² The Northern Hospital, Cardiology Department, Epping, Victoria, Australia; University of Melbourne, Parkville, Australia.

PMID: 25465512
DOI: 10.1016/j.hlc.2014.10.006

No abstract available

Keywords: Acute Coronary Syndrome; Bleeding; Dyspnoea; Female; Ticagrelor.

MeSH terms

Adenosine / administration & dosage
Adenosine / adverse effects
Adenosine / analogs & derivatives*
Aged
Female
Hemorrhage / chemically induced*
Hemorrhage / epidemiology*
Humans
Incidence
Male
Middle Aged
Percutaneous Coronary Intervention*
Purinergic P2Y Receptor Antagonists* / administration & dosage
Purinergic P2Y Receptor Antagonists* / adverse effects
Ticagrelor

Substances

Purinergic P2Y Receptor Antagonists
Ticagrelor
Adenosine